# PRCT (PROCEPT BioRobotics Corporation) - SEC EDGAR Financial Statements

> PROCEPT BioRobotics Corporation reported $352.3M in revenue and a net loss of $114.9M for the trailing twelve months ended September 30, 2026 (up 18.0% year over year), with a 64.7% gross margin and a -33.6% operating margin.

- Canonical: https://convexityos.com/fundamentals/PRCT
- Markdown: https://convexityos.com/fundamentals/PRCT.md
- SEC CIK: 0001588978
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:27 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001588978&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $352.3M | +18.0% YoY |
| Operating Income | TTM | -$118.4M | -33.6% margin |
| Net Income | TTM | -$114.9M | -32.6% net margin |
| Diluted EPS | TTM | -$2.00 | Split-adjusted |
| Free Cash Flow | TTM | -$85.07M | -24.1% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $218.4M | Total debt: $76.99M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $308.1M | $224.5M | $136.2M | $75.01M | $34.47M | $7.72M |
| Cost of Revenue | $111.8M | $87.40M | $65.14M | $37.93M | $18.61M | $8.97M |
| **Gross Profit** | $196.2M | $137.1M | $71.05M | $37.09M | $15.87M | -$1.25M |
| Research & Development | $71.28M | $62.30M | $48.45M | $28.98M | $18.99M | $16.27M |
| Selling, General & Admin | $228.8M | $171.4M | $131.8M | $88.83M | $51.04M | $30.27M |
| Total Operating Expenses | $300.1M | $233.7M | $180.2M | $117.8M | $70.03M | $46.55M |
| **Operating Income** | -$103.9M | -$96.61M | -$109.2M | -$80.72M | -$54.16M | -$47.80M |
| **EBITDA** | -$97.47M | -$91.38M | -$105.4M | -$77.88M | -$50.84M | -$44.94M |
| Interest Income | $12.22M | $10.89M | $7.55M | $2.50M | $76K | $184K |
| Interest Expense | $3.59M | $4.18M | $4.00M | $5.18M | $5.81M | $5.26M |
| Income Before Tax | -$95.38M | -$91.05M | -$105.8M | -- | -- | -- |
| Income Tax Expense | $190K | $368K | $80K | $0 | $0 | $0 |
| **Net Income** | -$95.57M | -$91.41M | -$105.9M | -$87.15M | -$59.85M | -$53.02M |
| Basic EPS | -$1.72 | -$1.75 | -$2.24 | -$1.96 | -$3.63 | -$14.47 |
| **Diluted EPS** | -$1.72 | -$1.75 | -$2.24 | -$1.96 | -$3.63 | -$14.47 |
| Basic Shares Outstanding | 55.5M | 52.1M | 47.3M | 44.4M | 16.5M | 3.7M |
| Diluted Shares Outstanding | 55.5M | 52.1M | 47.3M | 44.4M | 16.5M | 3.7M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $98.29M | $94.50M | $83.13M | $76.38M | $83.33M | $79.18M | $69.16M | $68.24M |
| Cost of Revenue | $33.14M | $32.12M | $29.18M | $30.07M | $29.32M | $27.44M | $25.00M | $24.56M |
| **Gross Profit** | $65.15M | $62.38M | $53.95M | $46.31M | $54.01M | $51.75M | $44.16M | $43.67M |
| Research & Development | $20.01M | $20.10M | $21.46M | $19.06M | $18.19M | $17.63M | $16.40M | $15.07M |
| Selling, General & Admin | $72.51M | $69.67M | $65.09M | $58.30M | $59.01M | $56.30M | $55.20M | $48.32M |
| Total Operating Expenses | $92.52M | $89.77M | $86.55M | $77.35M | $77.20M | $73.94M | $71.60M | $63.38M |
| **Operating Income** | -$27.38M | -$27.39M | -$32.61M | -$31.04M | -$23.19M | -$22.19M | -$27.44M | -$19.71M |
| **EBITDA** | -$24.84M | -$25.40M | -$30.87M | -$29.33M | -$21.57M | -$20.60M | -$25.96M | -$18.26M |
| Interest Expense | $856K | $842K | $818K | $894K | $919K | $895K | $877K | $969K |
| Income Before Tax | -$26.57M | -$26.77M | -$31.68M | -$29.78M | -$21.38M | -$19.44M | -$24.78M | -- |
| Income Tax Expense | -$58K | $94K | -$43K | $68K | $34K | $136K | -$47K | -- |
| **Net Income** | -$26.52M | -$26.86M | -$31.64M | -$29.84M | -$21.41M | -$19.58M | -$24.74M | -$18.86M |
| Basic EPS | -$0.46 | -$0.47 | -$0.56 | -- | -$0.38 | -$0.35 | -$0.45 | -- |
| **Diluted EPS** | -$0.46 | -$0.47 | -$0.56 | -- | -$0.38 | -$0.35 | -$0.45 | -- |
| Basic Shares Outstanding | 57.3M | 57.1M | 56.5M | -- | 55.7M | 55.4M | 54.9M | -- |
| Diluted Shares Outstanding | 57.3M | 57.1M | 56.5M | -- | 55.7M | 55.4M | 54.9M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $286.5M | $333.7M | $257.2M | $221.9M | $304.3M | $100.1M |
| **Cash & Short-Term Investments** | $286.5M | $333.7M | $257.2M | $221.9M | $304.3M | $100.1M |
| Accounts Receivable, Net | $83.53M | $83.50M | $48.38M | $15.27M | $4.46M | $1.55M |
| Inventory | $70.69M | $56.17M | $39.76M | $28.54M | $13.15M | $6.92M |
| **Total Current Assets** | $450.4M | $481.8M | $350.6M | $272.6M | $326.2M | $110.3M |
| Property, Plant & Equipment, Net | $30.40M | $26.71M | $28.75M | $8.66M | $5.04M | $8.27M |
| Other Non-Current Assets | $6.02M | $2.56M | $919K | $51K | $0 | -- |
| **Total Non-Current Assets** | $57.70M | $52.17M | $54.15M | $36.70M | $10.85M | $15.71M |
| **Total Assets** | $508.1M | $534.0M | $404.7M | $309.3M | $337.0M | $126.0M |
| Accounts Payable | $17.29M | $10.03M | $13.50M | $9.39M | $2.03M | $1.24M |
| Short-Term Debt | -- | -- | -- | -- | $0 | $4.55M |
| Deferred Revenue (Current) | $13.05M | $9.56M | $5.66M | $2.85M | $1.02M | $233K |
| Other Current Liabilities | $10.07M | $8.09M | $6.32M | $7.47M | $4.61M | $1.98M |
| **Total Current Liabilities** | $65.80M | $53.13M | $45.93M | $35.29M | $16.24M | $14.53M |
| Long-Term Debt | $51.62M | $51.47M | $51.34M | $51.21M | $50.00M | $44.41M |
| Deferred Revenue (Non-Current) | -- | -- | -- | $0 | -- | -- |
| Other Non-Current Liabilities | $147K | $324K | $517K | $0 | $200K | $200K |
| **Total Non-Current Liabilities** | $76.42M | $78.66M | $78.04M | $76.97M | $53.69M | $50.48M |
| **Total Liabilities** | $142.2M | $131.8M | $124.0M | $112.3M | $69.93M | $65.01M |
| **Total Debt (incl. Leases)** | $78.48M | $80.25M | $79.20M | $77.32M | $54.10M | $54.76M |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $0 |
| Retained Earnings | -$641.6M | -$546.0M | -$454.6M | -$348.7M | -$261.5M | -$201.7M |
| Accumulated Other Comp. Income | $37K | $114K | $84K | -$6.0K | -$54K | -$14K |
| **Total Stockholders' Equity** | $365.9M | $402.2M | $280.8M | $197.1M | $267.1M | -$182.9M |
| Total Equity | $365.9M | $402.2M | $280.8M | $197.1M | $267.1M | -$182.9M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $218.4M | $227.9M | $245.6M | $286.5M | $294.3M | $302.7M | $316.2M | $333.7M |
| **Cash & Short-Term Investments** | $218.4M | $227.9M | $245.6M | $286.5M | $294.3M | $302.7M | $316.2M | $333.7M |
| Accounts Receivable, Net | $105.0M | $107.6M | $96.39M | $83.53M | $84.50M | $80.82M | $79.27M | $83.50M |
| Inventory | $81.41M | $77.06M | $77.54M | $70.69M | $66.72M | $67.03M | $62.33M | $56.17M |
| **Total Current Assets** | $414.2M | $420.3M | $428.0M | $450.4M | $454.8M | $458.1M | $465.8M | $481.8M |
| Property, Plant & Equipment, Net | $30.16M | $31.83M | $31.74M | $30.40M | $30.02M | $28.60M | $28.13M | $26.71M |
| Other Non-Current Assets | $9.49M | $6.85M | $6.45M | $6.02M | $5.10M | $4.29M | $2.95M | $2.56M |
| **Total Non-Current Assets** | $59.57M | $59.07M | $59.03M | $57.70M | $56.79M | $54.99M | $53.58M | $52.17M |
| **Total Assets** | $473.8M | $479.4M | $487.1M | $508.1M | $511.5M | $513.1M | $519.4M | $534.0M |
| Accounts Payable | $16.72M | $15.07M | $18.85M | $17.29M | $11.12M | $11.78M | $14.83M | $10.03M |
| Deferred Revenue (Current) | $15.64M | $14.09M | $13.70M | $13.05M | $10.66M | $9.89M | $9.80M | $9.56M |
| Other Current Liabilities | $9.37M | $12.09M | $10.25M | $10.07M | $8.18M | $9.69M | $8.48M | $8.09M |
| **Total Current Liabilities** | $70.35M | $64.20M | $63.64M | $65.80M | $53.90M | $49.73M | $52.06M | $53.13M |
| Long-Term Debt | $51.77M | $51.72M | $51.66M | $51.62M | $51.57M | $51.52M | $51.50M | $51.47M |
| Other Non-Current Liabilities | $161K | $91K | $121K | $147K | $576K | $223K | $324K | $324K |
| **Total Non-Current Liabilities** | $74.50M | $75.09M | $75.76M | $76.42M | $77.37M | $77.53M | $78.15M | $78.66M |
| **Total Liabilities** | $144.9M | $139.3M | $139.4M | $142.2M | $131.3M | $127.3M | $130.2M | $131.8M |
| **Total Debt (incl. Leases)** | $76.99M | $77.50M | $78.00M | $78.48M | $78.93M | $79.37M | $79.81M | $80.25M |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Retained Earnings | -$726.6M | -$700.1M | -$673.2M | -$641.6M | -$611.7M | -$590.3M | -$570.7M | -$546.0M |
| Accumulated Other Comp. Income | $5.0K | $22K | -$19K | $37K | $42K | -$144K | $223K | $114K |
| **Total Stockholders' Equity** | $328.9M | $340.1M | $347.7M | $365.9M | $380.3M | $385.8M | $389.2M | $402.2M |
| Total Equity | $328.9M | $340.1M | $347.7M | $365.9M | $380.3M | $385.8M | $389.2M | $402.2M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$95.57M | -$91.41M | -$105.9M | -$87.15M | -$59.85M | -$53.02M |
| Depreciation & Amortization | $6.39M | $5.23M | $3.81M | $2.84M | $3.32M | $2.86M |
| Stock-Based Compensation | $47.60M | $31.84M | $19.13M | $10.34M | $3.80M | $2.17M |
| Change in Receivables | -$898K | -$35.96M | -$33.10M | -$10.81M | -$2.91M | -$511K |
| Change in Inventory | -$14.50M | -$17.23M | -$9.75M | -$15.25M | -$6.12M | -$3.10M |
| Change in Payables | $6.65M | -$2.15M | $5.79M | $3.96M | $812K | -$205K |
| **Operating Cash Flow** | -$48.98M | -$99.21M | -$108.0M | -$80.38M | -$57.33M | -$48.34M |
| Capital Expenditure | -$9.36M | -$4.41M | -$25.21M | -$2.65M | -$592K | -$233K |
| **Free Cash Flow** | -$58.34M | -$103.6M | -$133.2M | -$83.03M | -$57.93M | -$48.58M |
| **Investing Cash Flow** | -$9.36M | -$4.41M | -$25.21M | -$2.65M | -$592K | -$233K |
| Common Stock Issued | $0 | $164.5M | $161.7M | $0 | $0 | -- |
| **Financing Cash Flow** | $11.19M | $180.1M | $167.8M | $3.61M | $262.1M | $106.8M |
| **Net Change in Cash** | -$47.22M | $76.50M | $34.59M | -$79.42M | $204.2M | $58.20M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$26.52M | -$26.86M | -$31.64M | -$29.84M | -$21.41M | -$19.58M | -$24.74M | -$18.86M |
| Depreciation & Amortization | $2.54M | $1.99M | $1.74M | $1.71M | $1.62M | $1.59M | $1.48M | $1.45M |
| Stock-Based Compensation | $15.08M | $14.53M | $13.07M | $10.84M | $14.49M | $12.16M | $10.11M | $9.09M |
| Change in Receivables | $2.02M | -$11.63M | -$13.32M | $2.23M | -$4.35M | -$2.71M | $3.93M | -$14.83M |
| Change in Inventory | -$3.46M | $199K | -$7.03M | -$4.00M | $568K | -$4.79M | -$6.28M | -$5.80M |
| Change in Payables | $1.51M | -$2.85M | $1.54M | $5.93M | -$789K | -$2.25M | $3.75M | -$5.38M |
| **Operating Cash Flow** | -$8.98M | -$19.25M | -$38.13M | -$10.33M | -$6.63M | -$15.04M | -$16.98M | -$32.39M |
| Capital Expenditure | -$667K | -$2.95M | -$2.91M | -$1.85M | -$2.87M | -$2.80M | -$1.84M | -$1.17M |
| **Free Cash Flow** | -$9.65M | -$22.20M | -$41.04M | -$12.18M | -$9.50M | -$17.84M | -$18.82M | -$33.56M |
| **Investing Cash Flow** | -$667K | -$2.95M | -$2.91M | -$1.85M | -$2.87M | -$2.80M | -$1.84M | -$1.17M |
| **Financing Cash Flow** | $99K | $4.50M | $222K | $4.44M | $1.08M | $4.38M | $1.30M | $170.5M |
| **Net Change in Cash** | -$9.54M | -$17.73M | -$40.86M | -$7.78M | -$8.44M | -$13.49M | -$17.52M | $137.0M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 63.7% | 61.1% | 52.2% | 49.4% | 46.0% | -16.3% |
| **Operating Margin** | -33.7% | -43.0% | -80.2% | -107.6% | -157.1% | -619.4% |
| **Net Profit Margin** | -31.0% | -40.7% | -77.8% | -116.2% | -173.6% | -687.0% |
| Return on Equity (ROE) | -26.1% | -22.7% | -37.7% | -44.2% | -22.4% | -- |
| Return on Assets (ROA) | -18.8% | -17.1% | -26.2% | -28.2% | -17.8% | -42.1% |
| Current Ratio | 6.85x | 9.07x | 7.63x | 7.73x | 20.08x | 7.59x |
| Quick Ratio | 5.77x | 8.01x | 6.77x | 6.92x | 19.27x | 7.11x |
| Debt to Equity | 0.21x | 0.20x | 0.28x | 0.39x | 0.20x | -- |
| **Revenue Growth (YoY)** | +37.2% | +64.8% | +81.6% | +117.6% | +346.7% | -- |
| Gross Profit Growth (YoY) | +43.1% | +93.0% | +91.6% | +133.8% | -- | -- |
| 5Y Revenue / Share Growth | +163.3% | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 64.7% | 64.2% | 64.0% | 63.7% | 64.5% | 64.2% | 62.7% | 61.1% |
| **Operating Margin** | -33.6% | -33.9% | -33.9% | -33.7% | -30.9% | -33.4% | -38.7% | -43.0% |
| **Net Profit Margin** | -32.6% | -32.5% | -31.8% | -31.0% | -28.2% | -30.6% | -36.2% | -40.7% |
| Return on Equity (ROE) | -34.9% | -32.3% | -29.5% | -26.1% | -22.2% | -21.8% | -23.2% | -22.7% |
| Return on Assets (ROA) | -24.2% | -22.9% | -21.0% | -18.8% | -16.5% | -16.4% | -17.4% | -17.1% |
| Current Ratio | 5.89x | 6.55x | 6.73x | 6.85x | 8.44x | 9.21x | 8.95x | 9.07x |
| Quick Ratio | 4.73x | 5.35x | 5.51x | 5.77x | 7.20x | 7.86x | 7.75x | 8.01x |
| Debt to Equity | 0.23x | 0.23x | 0.22x | 0.21x | 0.21x | 0.21x | 0.21x | 0.20x |
| **Revenue Growth (YoY)** | +18.0% | +19.3% | +20.2% | +11.9% | +42.8% | +48.4% | +55.3% | +56.6% |
| Gross Profit Growth (YoY) | +20.6% | +20.5% | +22.2% | +6.0% | +46.3% | +64.4% | +76.4% | +105.5% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
